Macclesfield, United Kingdom

Remy Robert Morgentin

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Reims, FR (2013 - 2014)
  • Macclesfield, GB (2015 - 2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Remy Robert Morgentin: Innovator in Chromenone Derivatives

Introduction

Remy Robert Morgentin is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his work on chromenone derivatives. With a total of four patents to his name, Morgentin's innovations are paving the way for advancements in the treatment of cell proliferative disorders.

Latest Patents

Morgentin's latest patents focus on chromenone derivatives, which are described as pharmaceutically-acceptable salts of a specific formula. These derivatives are crucial for developing pharmaceutical compositions aimed at treating various cell proliferative disorders. The processes for their preparation and the potential applications in medicament manufacturing highlight the importance of his work in the medical field.

Career Highlights

Morgentin is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His work is instrumental in advancing therapeutic options for patients.

Collaborations

Morgentin has worked alongside notable colleagues, including Christine Marie Paul Lambert-Van Der Brempt and Patrick Ple. These collaborations enhance the innovative environment in which he operates, fostering the exchange of ideas and expertise.

Conclusion

Remy Robert Morgentin's contributions to the field of pharmaceuticals through his patents on chromenone derivatives demonstrate his commitment to innovation and improving healthcare. His work at AstraZeneca and collaborations with other professionals further solidify his impact in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…